Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States
Open Access
- 23 June 2020
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (24), 2524-2526
- https://doi.org/10.1001/jama.2020.9184
Abstract
Conflicting information regarding the benefits of hydroxychloroquine/chloroquine and azithromycin in coronavirus disease 2019 (COVID-19) treatment and hypothetical concerns for drugs, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), have challenged care during the pandemic.1 However, limited data are available about how prescription of these therapies has changed. The objective of this exploratory analysis was to evaluate prescription patterns of these therapies, along with other commonly used drugs for reference, in the United States during the COVID-19 pandemic. We hypothesized that the prescription of hydroxychloroquine/chloroquine and azithromycin would exceed historical estimates while ACE inhibitor/ARB use would be reduced.Keywords
This publication has 4 references indexed in Scilit:
- Internet Searches for Unproven COVID-19 Therapies in the United StatesJAMA Internal Medicine, 2020
- Faculty Opinions recommendation of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19.Published by H1 Connect ,2020
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19The New England Journal of Medicine, 2020
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020